"So why would Suzy Jones previously the head of business development at a multi billion dollar pharmaceutical company come here? with a micro cap of $11M but a portfolio of novel human antibody treatments for cancer entering clinical trials & setting up to be outlicensed."
I should of made this more clear in my post aswell, it was the end of a 4 day weekend.. :-)
Genentech was not so much a pharmaceutical company as the oldest & largest R&D company before Roche stepped up & took out the remaining stake they didn't already own. So Suzy Jones as Head of Business Development at the largest & oldest R&D company globally with it's top of the line focus in Oncology & antibody drugs in market.
You think she's here because the science sucks ?
- Forums
- ASX - By Stock
- PAB
- the demise of csl
the demise of csl, page-9
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $3.274K | 1.087M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 34098412 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 26755974 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 34098412 | 0.003 |
26 | 28721332 | 0.002 |
14 | 54551998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 26755974 | 14 |
0.005 | 11226512 | 10 |
0.006 | 3371450 | 5 |
0.007 | 6601356 | 5 |
0.008 | 1221910 | 4 |
Last trade - 12.37pm 04/10/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |